Molecular comparison of pure ovarian fibroma with serous benign ovarian tumours

被引:6
|
作者
Hunter, Sally M. [1 ]
Dall, Genevieve V. [1 ]
Doyle, Maria A. [2 ]
Lupat, Richard [2 ]
Li, Jason [2 ]
Allan, Prue [3 ]
Rowley, Simone M. [1 ]
Bowtell, David [1 ,4 ,5 ]
Campbell, Ian G. [1 ,4 ,5 ]
Gorringe, Kylie L. [1 ,4 ,5 ,6 ]
机构
[1] Peter MacCallum Canc Ctr, Canc Genom Program, East Melbourne, Australia
[2] Peter MacCallum Canc Ctr, Bioinformat Core Facil, East Melbourne, Vic, Australia
[3] Peter MacCallum Canc Ctr, Anat Pathol, East Melbourne, Vic, Australia
[4] Univ Melbourne, Dept Pathol, Parkville, Vic, Australia
[5] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic, Australia
[6] Peter MacCallum Canc Ctr, Locked Bag 1,ABeckett St, Melbourne, Vic 8006, Australia
基金
英国医学研究理事会;
关键词
Ovarian fibroma; Adenofibroma; Cystadenomas; Cystadenofibroma; Copy number aberrations; Gene expression; Exome sequencing; Microarrays; NUMERICAL CHROMOSOME-ABERRATIONS; SITU HYBRIDIZATION ANALYSIS; SOMATIC POINT MUTATIONS; STROMAL CELL TUMORS; CLINICAL-SIGNIFICANCE; EXPRESSION; CANCER; TRISOMY-12; PROLIFERATION; PRAME;
D O I
10.1186/s13104-020-05194-z
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
ObjectiveOvarian fibromas and adenofibromas are rare ovarian tumours. They are benign tumours composed of spindle-like stromal cells (pure fibroma) or a mixture of fibroblast and epithelial components (adenofibroma). We have previously shown that 40% of benign serous ovarian tumours are likely primary fibromas due to the neoplastic alterations being restricted to the stromal compartment of these tumours. We further explore this finding by comparing benign serous tumours to pure fibromas.ResultsPerforming copy number aberration (CNA) analysis on the stromal component of 45 benign serous tumours and 8 pure fibromas, we have again shown that trisomy of chromosome 12 is the most common aberration in ovarian fibromas. CNAs were more frequent in the pure fibromas than the benign serous tumours (88% vs 33%), however pure fibromas more frequently harboured more than one CNA event compared with benign serous tumours. As these extra CNA events observed in the pure fibromas were unique to this subset our data indicates a unique tumour evolution. Gene expression analysis on the two cohorts was unable to show gene expression changes that differed based on tumour subtype. Exome analysis did not reveal any recurrently mutated genes.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Ovarian-type epithelial tumours of the testis: immunohistochemical and molecular analysis of two serous borderline tumours of the testis
    Tobias Bürger
    Hans-Ulrich Schildhaus
    Reinhard Inniger
    Joachim Hansen
    Peter Mayer
    Stefan Schweyer
    Heinz Joachim Radzun
    Philipp Ströbel
    Felix Bremmer
    Diagnostic Pathology, 10
  • [32] Expression of Claudin 3 and Claudin 4 in Serous Borderline Ovarian Tumours and Low-Grade Serous Ovarian Carcinomas
    Uthayanan, L.
    Wang, Z.
    El-Bahrawy, M.
    JOURNAL OF PATHOLOGY, 2022, 256 : S12 - S12
  • [33] Ultrasound-Guided Laparoscopic Ovarian Wedge Resection in Recurrent Serous Borderline Ovarian Tumours
    Jones, Benjamin P.
    Saso, Srdjan
    Farren, Jessica
    El-Bahrawy, Mona
    Ghaem-Maghami, Sadaf
    Smith, J. Richard
    Yazbek, Joseph
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 (09) : 1813 - 1818
  • [34] Increased concentrations of neopterin in plasma, ascites and ovarian cyst fluid in malignant tumours compared with benign ovarian tumours
    Haeger, M
    Swahn, M
    Hahlin, M
    Horvath, G
    Bengtsson, A
    ANTICANCER RESEARCH, 1996, 16 (5B) : 3189 - 3192
  • [35] Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genes
    Hunter, Sally M.
    Anglesio, Michael S.
    Ryland, Georgina L.
    Sharma, Raghwa
    Chiew, Yoke-Eng
    Rowley, Simone M.
    Doyle, Maria A.
    Li, Jason
    Gilks, C. Blake
    Moss, Phillip
    Allan, Prue E.
    Stephens, Andrew N.
    Huntsman, David G.
    deFazio, Anna
    Bowtell, David D.
    Gorringe, Kylie L.
    Campbell, Ian G.
    ONCOTARGET, 2015, 6 (35) : 37663 - 37677
  • [36] Lactose and benign ovarian tumours in a case–control study
    J A Britton
    C Westhoff
    G R Howe
    M D Gammon
    British Journal of Cancer, 2000, 83 : 1552 - 1555
  • [37] SERUM MARKERS AND CYTOKINES IN PATIENTS WITH OVARIAN CANCER, ENDOMETRIOSIS OR OTHER BENIGN OVARIAN TUMOURS
    Nowak, Marek
    Misiek, Marcin
    Janas, Lukasz
    Piwowarczyk, Iwona
    Soja, Malwina
    Masternak, Martyna
    Glowacka, Ewa
    Kielbik, Michal
    Szulc-Kielbik, Izabela
    Klink, Magdalena
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : A60 - A60
  • [38] Venous Thromboembolic Complications in Patients with Ovarian Cancer compared to Patients with Benign Ovarian Tumours
    Kahr, H. Strom
    Knudsen, A.
    Christiansen, O. B.
    Grove, A.
    Iyer, V.
    Thorlacius-Ussing, O.
    THROMBOSIS RESEARCH, 2018, 164 : S215 - S215
  • [39] Measurement of glycodelin A in fluids of benign ovarian cysts, borderline tumours and malignant ovarian cancer
    Bischof, A
    Briese, V
    Richter, DU
    Bergemann, C
    Friese, K
    Jeschke, U
    ANTICANCER RESEARCH, 2005, 25 (3A) : 1639 - 1644
  • [40] Venous Thromboembolic Complications in Patients with Ovarian Cancer compared to Patients with Benign Ovarian Tumours
    Kahr, H. S.
    Knudsen, A.
    Christiansen, O. B.
    Grove, A.
    Iyer, V.
    Thorlacius-Ussing, O.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 738 - 738